Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Highly effective and yet non-harmful: Fumaric acid esters to fight MS

26.03.2013
Firewall for nerve cells: RUBIN covers research reports
Success made in Bochum: Treatment of relapsing-remitting multiple sclerosis

Multiple sclerosis (MS) is a disease for which no cure has yet been found. Its progression may be delayed thanks to new drugs, but the active ingredients in those drugs are either only partially effective or may lead to severe side effects.

Recent developments in the field of dermatology have given rise to hope. Researchers in Bochum have discovered that MS symptoms are considerably alleviated through the application of an active pharmaceutical ingredient on the basis of fumaric acid that has long been successfully used against psoriasis.

Patients suffered 50% fewer flare-ups and the number of active inflammatory foci was reduced by up to 90%. Researchers have now discovered in what way fumaric acid esters protect nerve cells. Their report has been published in the international edition of RUBIN, the science magazine issued by the Ruhr University Bochum.

RUBIN online

The complete article with downloadable images may be found online at
http://www.ruhr-uni-bochum.de/rubin/rubin-international-2013/beitraege/beitrag1.html

MS: Most common neurological cause of disabilities in young adults.

Multiple sclerosis is the most common neurological cause of disabilities in young adults. In Germany, it currently affects some 130,000 patients. In MS patients, the body’s own immune system attacks the nerve fibres’ “insulating layer” and destroys it. Typically, all regions of the brain and the spinal cord are affected as the disease progresses. The inflammations result in ataxia, impairment of fine motor skills, as well as concentration loss, bladder function impairment, fatigue and depressive episodes.

Fruit acid approved for use in the food industry

Since the 1990s, various drugs that delay the progression of the disease by altering the immune system have been available. They are not harmful, yet their efficacy is quite limited. Particularly serious cases are treated with chemotherapeutic agent, which, however, may have severe, even life-threatening side effects. Researchers in Bochum have now discovered that an agent long known in the field of dermatology is highly effective in the treatment of MS episodes: fumaric acid ester. Fumaric acid is a fruit acid found in numerous plants and an approved food acidulant that also occurs naturally in the human body. The active agent has been successfully utilised in psoriasis therapy.

50% fewer episodes, 90% fewer inflammation foci

The discovery happened quite by accident: the MS symptoms of patients who suffered from both MS and psoriasis were alleviated following fumaric acid ester treatment. Accordingly, several studies were carried out. Prof Dr Ralf Gold’s team of neurologists have now presented the proof of fumaric acid ester’s efficacy: it triggers protective metabolic pathways in cells. “Nerve cells are thus protected, as if by a firewall, from inflammatory agents, mainly from free radicals and nitrogen monoxide,” explains Prof Gold. A large-scale study with more than 2,400 patients revealed that fumaric acid esters reduce MS episode frequency by up to 50% and the number of inflammatory foci visible in MRI scans by up to 90%. By changing the drug formula, indigestion, a common side effect of fumaric acid ester occurring in some 400 patients treated by the dermatological drug has been considerably reduced to some 3% to 5%. “Highly efficient and yet non-harmful – a wholly new experience in MS therapy!” Prof Gold says happily.
Bibliographic record

Ralf Gold et al.: Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis. In: N Engl J Med 2012; 367:1098-1107, September 20, 2012, DOI: 10.1056/NEJMoa1114287

Further information

Prof Dr med Ralf Gold, Director at the Neurology Clinic of the Ruhr University Bochum at St. Josef-Hospital, phone 0234/509-2410, ralf.gold@rub.de

Editor: Meike Drießen

Dr. Josef König | idw
Further information:
http://www.ruhr-uni-bochum.de/rubin/rubin-international-2013/beitraege/beitrag1.html

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

Meter-sized single-crystal graphene growth becomes possible

22.08.2017 | Materials Sciences

Repairing damaged hearts with self-healing heart cells

22.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>